1. Home
  2. NAVI vs NVCR Comparison

NAVI vs NVCR Comparison

Compare NAVI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navient Corporation

NAVI

Navient Corporation

HOLD

Current Price

$8.63

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$13.33

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAVI
NVCR
Founded
1973
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NAVI
NVCR
Price
$8.63
$13.33
Analyst Decision
Sell
Buy
Analyst Count
7
6
Target Price
$12.14
$28.08
AVG Volume (30 Days)
1.0M
2.8M
Earning Date
01-01-0001
05-20-2026
Dividend Yield
7.42%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$82.46
$7.72
Revenue Next Year
$12.45
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$8.36
$9.82
52 Week High
$16.07
$21.55

Technical Indicators

Market Signals
Indicator
NAVI
NVCR
Relative Strength Index (RSI) 22.71 55.91
Support Level N/A $12.66
Resistance Level $13.34 $14.13
Average True Range (ATR) 0.34 1.17
MACD 0.01 0.33
Stochastic Oscillator 16.00 59.79

Price Performance

Historical Comparison
NAVI
NVCR

About NAVI Navient Corporation

Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in three segments: Federal Education Loans, Consumer Lending, and Business Processing. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: